Moving iMage Technologies, Inc. — Form 10-Q Summary
Reporting period: The filing covers the quarter and nine months ended March 31, 2024 (the company’s fiscal third quarter of 2024), not 2023 Q3 as stated in the request metadata. Financial statements are unaudited.
Business context
The company designs, integrates, installs and distributes cinema and venue equipment, including proprietary products, and provides project management, technical services and software. Its results are sensitive to cinema construction and refurbishment activity, film release schedules, customer orders and product mix.
Financial performance and liquidity
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Net sales | 2024: $3.890 million; 2023: $3.741 million | 2024: $13.790 million; 2023: $14.435 million |
| Gross profit and margin | 2024: $0.676 million, 17.4%; 2023: $1.042 million, 27.9% | 2024: $3.254 million, 23.6%; 2023: $3.912 million, 27.1% |
| Operating loss | 2024: $0.649 million; 2023: $0.526 million | 2024: $1.096 million; 2023: $0.614 million |
| Net loss | 2024: $0.601 million; 2023: $0.424 million | 2024: $0.956 million; 2023: $0.472 million |
| Operating cash flow | Not separately presented for the quarter | 2024: cash used of $0.337 million; 2023: cash used of $0.685 million |
Quarterly sales rose 4.0%, but gross profit fell 35.1%, primarily because of lower-margin equipment and seat revenues. For the nine-month period, sales fell 4.5% and gross profit fell 16.8%. Lower operating expenses partly offset the gross-profit decline. Basic and diluted loss per share was $0.06 for the quarter and $0.09 for the nine months, versus $0.04 in each comparable 2023 period.
Cash was $5.946 million at March 31, 2024, down from $6.616 million at June 30, 2023. Current assets were $11.994 million and current liabilities were $6.375 million, implying working capital of approximately $5.619 million. The balance sheet reports no borrowings; lease liabilities totaled $0.224 million, all current. Total liabilities were $6.375 million. Management believes available liquidity and operating cash flow will be sufficient for at least 12 months from issuance of the statements.
Cash used in investing activities was $0.012 million in the nine months ended March 31, 2024, mainly for equipment purchases. Financing activities used $0.321 million, principally for share repurchases, partly offset by shares issued for director fees. The company repurchased 418,745 shares during the period at an average price of $0.78 per share.
Material changes and management commentary
- Management attributed weaker nine-month sales and reduced theater construction to fewer film releases, including effects of the 2023 SAG-AFTRA strike. It also cited evolving release windows, streaming competition, supply-chain delays, inflation and labor pressures.
- Inventory reserves increased to $1.017 million from $0.584 million at June 30, 2023. The cash-flow statement includes a $0.433 million inventory-reserve adjustment.
- Customer deposits rose to $3.895 million from $3.169 million. One customer represented 12% of nine-month sales and had approximately $0.176 million of receivables outstanding at March 31, 2024.
- On April 1, 2024, the board authorized a new share repurchase program of up to $0.363 million, expiring June 30, 2024 or when the authorization is used. On May 8, the board authorized a $25,000 payment to the CEO associated with a salary increase from $200,000 to $250,000 annually, effective November 1, 2023.
- No specific financial guidance was provided. Management plans to invest in sales, support, product development and infrastructure, and expects operating expenses to increase as it pursues growth. Management cited potential higher-margin products, including an accessibility and multilingual system and Direct View LED screens.
Risks, controls and contingencies
The filing identifies risks from cinema-industry conditions, customer order changes, seasonality, competition and pricing, supplier relationships, product acceptance, content-related labor disputes, supply-chain and labor disruptions, and other economic or catastrophic events. Management says the pandemic and industry recovery continue to adversely affect the business. The company reported no material pending legal proceedings and no material changes to the risk factors in its fiscal 2023 Form 10-K.
Management concluded that disclosure controls and procedures were not effective as of March 31, 2024 because of material weaknesses in financial reporting processes, documented accounting policies and procedures, segregation of duties, and journal-entry review. Remediation measures include updated close checklists, improved segregation of duties and formal CFO approval of month-end journal entries. No material change in internal control occurred during the quarter.
Important facts for investors to verify
- Confirm the reporting-period designation: this is a Form 10-Q for the quarter ended March 31, 2024, despite the request’s “2023 Q3” label.
- Reconcile an MD&A inconsistency: the three-month results discussion cites 2023 gross profit as $1.402 million in one sentence, while the financial statements report $1.042 million.
- Reconcile another MD&A inconsistency: it describes nine-month 2023 investing cash flow as cash used of $4.751 million, while the cash-flow statement reports $4.751 million provided, principally reflecting net marketable-security activity.
- Monitor gross-margin pressure, inventory reserves and inventory realizability, cinema construction demand, and the company’s ability to sustain cash while reporting losses.
- Track progress on the disclosed control weaknesses and the timing and terms of share repurchases and the CEO compensation change.